Read Frequently Asked Questions
ICH Q10 - Moving From GMPs To A Pharmaceutical Quality System
This ICH Q10 training /webinar will discuss the evolution and interpretation of the pharmaceutical GMPs as a quality control regulation to the Quality Assurance emphasis of the Pharmaceutical Quality System as defined in ICH Q10.
Why Should You Attend:
Since the release of the Quality System Regulation for medical devices, the FDA has been trying to transition the pharmaceutical industry to a Quality System approach to compliance. The issuance of the Guidance for the Industry: Quality System Approach to Pharmaceutical CGMPS and ICH Q10. Pharmaceutical Quality System has brought new focus to Quality Systems in the pharmaceutical industry. This seminar will discuss the transition in the FDA oversight from a strict audit against the regulations as defined in the GMPs to a review of the high level quality system and the involvement of senior management in compliance to the GMPs.
The discussion will begin with the establishment of ICH and its original purpose to facilitate registrations throughout the world and discuss the impact of Quality systems such as ISO 9000 and the medical device GMPs. It will continue with the effort of the agency to change the way it regulates and the impact of the international focus on Quality Systems and how ICH broadened its scope and responded to the international move to a quality systems approach.
This seminar will discuss the evolution and interpretation of the pharmaceutical GMPs as a quality control regulation to the Quality Assurance emphasis of the Pharmaceutical Quality System as defined in ICH Q10, Pharmaceutical Quality System and the FDA Guidance, Quality System Approach to Pharmaceutical CGMPs with a focus on the involvement of senior management in the accomplishment of the quality objectives of the pharmaceutical firm. This session will help the participants understand the Pharmaceutical Quality System and how it might be implemented.
Areas Covered in the Webinar:
- ICH - original scope of activities.
- Systems based inspections and other quality systems.
- The new role of ICH - ICH Q7, ICH Q8, ICH Q9.
- Quality System Approach to Pharmaceutical CGMPs.
- ICH Q10, Pharmaceutical Quality System.
- Other, non-industry quality standards.
- Transitioning to the Pharmaceutical Quality System.
Who Will Benefit:
- Senior management representing all departments or units
- QA directors who will be responsible for the implementation of a quality system
- Middle management
Dr. John G. (Jerry) Lanese, PH.D. CMC is the President of The Lanese Group, Inc, an independent consulting service provider that specializes in Quality Systems and Laboratory Controls. Jerry has taught at the college level and worked in various Quality Control and Quality Assurance roles in small and large pharmaceutical firms. For the last 15 years he has consulted in a wide range of projects from consent decree remedial actions with large pharmaceutical firms to systems development for a small component manufacturer. He has lectured throughout the world to clients and for major seminar providers. He was voted the best presenter of the year in 2001 by the Institute of Validation Technology. In 2008 he received the Kenneth Chapman Industry Recognition Award.
ComplianceOnline would process/provide refund only if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange. Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs."
For substitution, please email email@example.com or call +1-650-620-3937.
This training hasn't been reviewed yet.
John G Lanese
Laboratory Controls - Preparing for a Systems Based Inspection Thorough and Complete Investigations and Follow-Up - A Current Regulatory Expectation Out-of-Specification Investigations, Identifying the Attributable cause or Laboratory Error Out-of-Specification Investigations - Beyond the laboratory